FDA Recalls Millions of Rohto Eye Drops Due to Sterility Concerns

The U.S. Food and Drug Administration (FDA) has announced a Class II recall of nearly 12 million Rohto cooling eye drop products nationwide. The manufacturer, Rohto-Mentholatum (Vietnam) Co., Ltd., initiated the recall over a lack of sterility assurance. This issue means the products could potentially cause temporary or medically reversible adverse health effects for users.